Skip to content
10-Q

Quarterly Report

Xenon Pharmaceuticals Inc. XENE

0001193125-25-262646

← back to feed
Filed
Nov 3, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 30, 2025 77.28M sh
Shares Diluted Q3 2025 · Sep 30, 2025 79.25M sh
Shares Diluted Q3 2025 · Sep 30, 2025 78.96M sh
Shares Diluted Q3 2025 · Sep 30, 2024 77.93M sh
Shares Diluted Q3 2025 · Sep 30, 2024 77.73M sh
Capex Q3 2025 · Sep 30, 2025 $481K
Capex Q3 2025 · Sep 30, 2024 $2.29M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$197.64M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$127M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $104.51M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $142.71M
Stockholders Equity Q3 2025 · Sep 30, 2025 $559.51M
Stockholders Equity Q3 2025 · Jun 30, 2025 $633.98M
Stockholders Equity Q3 2025 · Mar 31, 2025 $703.96M
Stockholders Equity Q3 2025 · Dec 31, 2024 $754.9M
Stockholders Equity Q3 2025 · Sep 30, 2024 $797.81M
Stockholders Equity Q3 2025 · Jun 30, 2024 $844.05M
Stockholders Equity Q3 2025 · Mar 31, 2024 $887.7M
Stockholders Equity Q3 2025 · Dec 31, 2023 $927.92M
Current Liabilities Q3 2025 · Sep 30, 2025 $38.34M
Current Liabilities Q3 2025 · Dec 31, 2024 $35.59M
Total Liabilities Q3 2025 · Sep 30, 2025 $48.33M
Total Liabilities Q3 2025 · Dec 31, 2024 $43.24M
Current Assets Q3 2025 · Sep 30, 2025 $480.14M
Current Assets Q3 2025 · Dec 31, 2024 $635.26M
Total Assets Q3 2025 · Sep 30, 2025 $607.84M
Total Assets Q3 2025 · Dec 31, 2024 $798.14M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.15
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.05
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.81
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.17
Eps Basic Q3 2025 · Sep 30, 2025 −$1.15
Eps Basic Q3 2025 · Sep 30, 2025 −$3.05
Eps Basic Q3 2025 · Sep 30, 2024 −$0.81
Eps Basic Q3 2025 · Sep 30, 2024 −$2.17
Sga Expense Q3 2025 · Sep 30, 2025 $19.28M
Sga Expense Q3 2025 · Sep 30, 2025 $57.56M
Sga Expense Q3 2025 · Sep 30, 2024 $16.71M
Sga Expense Q3 2025 · Sep 30, 2024 $50.9M
Rd Expense Q3 2025 · Sep 30, 2025 $77.05M
Rd Expense Q3 2025 · Sep 30, 2025 $213.24M
Rd Expense Q3 2025 · Sep 30, 2024 $56.97M
Rd Expense Q3 2025 · Sep 30, 2024 $150.92M
Net Income Q3 2025 · Sep 30, 2025 −$90.9M
Net Income Q3 2025 · Sep 30, 2025 −$240.65M
Net Income Q3 2025 · Jun 30, 2025 −$84.71M
Net Income Q3 2025 · Mar 31, 2025 −$65.05M
Net Income Q3 2025 · Sep 30, 2024 −$62.79M
Net Income Q3 2025 · Sep 30, 2024 −$168.65M
Net Income Q3 2025 · Jun 30, 2024 −$57.92M
Net Income Q3 2025 · Mar 31, 2024 −$47.93M
Operating Income Q3 2025 · Sep 30, 2025 −$96.34M
Operating Income Q3 2025 · Sep 30, 2025 −$263.3M
Operating Income Q3 2025 · Sep 30, 2024 −$73.68M
Operating Income Q3 2025 · Sep 30, 2024 −$201.82M